LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 20.13

Change

-0.01 (-0.05)%

Market Cap

CAD 0.21B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.07 (+0.15%)

CAD 3.39B
ZWU:CA BMO Covered Call Utilities ETF

+0.01 (+0.09%)

CAD 1.82B
XIT:CA iShares S&P/TSX Capped Informa..

+0.18 (+0.25%)

CAD 0.78B
TXF:CA First Asset Tech Giants Covere..

+0.03 (+0.14%)

CAD 0.66B
HTA:CA Harvest Tech Achievers Growth ..

-0.01 (-0.05%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

+0.69 (+1.03%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.17 (+0.79%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.28 (+1.01%)

CAD 0.40B
CWW:CA iShares Global Water Common Cl..

+0.07 (+0.12%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

+1.02 (+1.52%)

CAD 0.28B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.52% 63% D 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.52% 63% D 77% C+
Trailing 12 Months  
Capital Gain -5.89% 9% A- 13% F
Dividend Return 4.49% 72% C 65% D
Total Return -1.40% 11% F 14% F
Trailing 5 Years  
Capital Gain -6.24% 17% F 32% F
Dividend Return 35.89% 85% B 91% A-
Total Return 29.65% 29% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 0.81% 17% F 34% F
Dividend Return 1.98% 9% A- 31% F
Total Return 1.17% 56% F 45% F
Risk Return Profile  
Volatility (Standard Deviation) 6.97% 97% N/A 85% B
Risk Adjusted Return 28.42% 26% F 42% F
Market Capitalization 0.21B 62% D 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.